Triethylamine → HCID 67517382, compound
Reaction equation
[C:1]([C:4]1[C:12]2[O:11][CH2:10][CH:9]([CH2:13][N:14]3[CH2:19][CH2:18][N:17]([C:20]([O:22][C:23]([CH3:26])([CH3:25])[CH3:24])=[O:21])[CH2:16][CH2:15]3)[C:8]=2[CH:7]=[CH:6][CH:5]=1)(=O)[NH2:2].CCN(CC)CC.C(OC(C(F)(F)F)=O)(C(F)(F)F)=O>C(Cl)Cl>[C:1]([C:4]1[C:12]2[O:11][CH2:10][CH:9]([CH2:13][N:14]3[CH2:19][CH2:18][N:17]([C:20]([O:22][C:23]([CH3:26])([CH3:25])[CH3:24])=[O:21])[CH2:16][CH2:15]3)[C:8]=2[CH:7]=[CH:6][CH:5]=1)#[N:2]Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 0 °C
Procedure
A solution of tert-butyl 4-[(7-carbamoyl-2,3-dihydro-1-benzofuran-3-yl)methyl]piperazine-1-carboxylate in DCM (80 mg, 0.22 rnmol) was added Et3N (60 mg, 0.59 mmol). The solution was cooled to 0° C. and TFAA (60 mg, 0.29 mmol) was added dropwise under nitrogen. After 4 hours stirring at room temperature, the solvents were removed under vacuum to give the crude product tert-butyl 4-[(7-cyano-2,3-dihydro-1-benzofuran-3-yl)methyl]piperazine-1-carboxylate (66 g, yield 87%) which was used for next step without purification.
Workup
- customthe solvents were removed under vacuum
Sources & evidence
- ORD record
- ord-cb4d1ab874574658ab5c40eea6c9f270
- Source dataset
- uspto-grants-2015_06
- Patent number
- US09056859B2
Reaction notes
Loading…